Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

NCT01435226

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: University of Arizona Tucson, Arizona, United States

Advanced Clinical Research Institute, LLC Anaheim, California, United States

California Liver Institute Beverly Hills, California, United States

SCTI Research Foundation Liver Center Coronado, California, United States

View all 51 locations

View Trial Details

Completed

WEUSKOP5410: Observational Study in ENABLE Clinical Trials

NCT01458080

Conditions: Blood Platelet Disorders, Blood-Borne Infections, Cardiovascular Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

NCT00056862

Conditions: Agranulocytosis, Anemia, Anemia, Hemolytic, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

NCT00996216

Conditions: Blood Platelet Disorders, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site San Diego, California, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Honolulu, Hawaii, United States

GSK Investigational Site Manhasset, New York, United States

View all 28 locations

View Trial Details

Completed

Celgosivir as a Treatment Against Dengue

NCT01619969

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: Singapore General Hospital Singapore

View Trial Details

Completed

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

NCT01258686

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Byung Chul, Yoo Seoul, South Korea

View Trial Details

Completed

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

NCT00831012

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +9 more
Locations: Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

NCT01600976

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Prague, Czechia

Kiel, Germany

View Trial Details

Completed

Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease

NCT01886599

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Orlando Clinical Research Center Orlando, Florida, United States

Davita Clinical Research Minneapolis, Minnesota, United States

New Orleans Center For Clinical Research Knoxville, Tennessee, United States

View Trial Details

Completed

Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease

NCT00028093

Conditions: Anemia, Anemia, Hemolytic, Blood-Borne Infections, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions